These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 741221)

  • 41. [Experimental studies on the antitumor effect of progesterone and enhancement of the therapeutic effect of anticancer drugs by progesterone--from the aspect of zinc metabolism].
    Ujiie S; Mimata Y; Okuno M; Wakui A
    Gan To Kagaku Ryoho; 1989 Jul; 16(7):2423-8. PubMed ID: 2751319
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interactions with human blood in vitro and pharmacokinetic properties in mice of liposomal N4-octadecyl-1-beta-D-arabinofuranosylcytosine, a new anticancer drug.
    Koller-Lucae SK; Schott H; Schwendener RA
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1572-80. PubMed ID: 9316874
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chemoimmunotherapy for autochthonous acute rat leukemias.
    Zeller WJ; Reusch K; Schmähl D
    Cancer Treat Rep; 1982 Feb; 66(2):391-4. PubMed ID: 7055821
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacokinetics of 1-beta-D-arabinofuranosylcytosine in humans.
    Wan SH; Huffman DH; Azarnoff DL; Hoogstraten B; Larsen WE
    Cancer Res; 1974 Feb; 34(2):392-7. PubMed ID: 4521089
    [No Abstract]   [Full Text] [Related]  

  • 45. In vitro evaluation of 1-beta-D-arabinofuranosylcytosine-beta-2'-deoxythioguanosine combination chemotherapy.
    Rao PN; Freireich EJ; Bodey GP; Gottlieb JA; Smith ML
    Cancer Res; 1974 Oct; 34(10):2539-43. PubMed ID: 4472144
    [No Abstract]   [Full Text] [Related]  

  • 46. [Pharmacokinetics of N4-behenoyl-1-beta-D-arabinofuranosylcytosine after intraperitoneal administration].
    Noda T; Oku M; Kiyozuka Y; Maruyama M; Adachi S; Akada S; Okamura Y; Ichijo M
    Gan To Kagaku Ryoho; 1988 Oct; 15(10):2929-35. PubMed ID: 3178241
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enzyme catalyzation of the deacylation of N4-acyl derivatives of 1-beta-D-arabinofuranosylcytosine in the mouse liver microsome.
    Tsuruo T; Hori K; Iida H; Tsukagoshi S; Sakurai Y
    Cancer Res; 1982 Jun; 42(6):2250-4. PubMed ID: 7074607
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Production of N4-succinyl-1-beta-D-arabinofuranosylcytosine, a novel metabolite of N4-behenoyl-1-beta-D-arabinofuranosylcytosine, in mice and its biological significance.
    Oh-ishi J; Kataoka T; Tsukagoshi S; Sakurai Y; Shibukawa M; Kobayashi H
    Cancer Res; 1981 Jun; 41(6):2501-6. PubMed ID: 7237444
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-term effects of flavone acetic acid on the growth of a rat tumour.
    Bowler K; Pearson JA
    Anticancer Res; 1992; 12(4):1275-9. PubMed ID: 1503421
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Therapy of central nervous system leukemia in mice by liposome-entrapped 1-beta-D-arabinofuranosylcytosine.
    Hong F; Mayhew E
    Cancer Res; 1989 Sep; 49(18):5097-102. PubMed ID: 2766280
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacokinetics of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in leukemic cells after intravenous and subcutaneous administration of 1-beta-D-arabinofuranosylcytosine.
    Liliemark JO; Paul CY; Gahrton CG; Peterson CO
    Cancer Res; 1985 May; 45(5):2373-5. PubMed ID: 3986778
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [590-S].
    Furue H
    Gan No Rinsho; 1985 May; 31(6 Suppl):739-45. PubMed ID: 4032755
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Histidinol-mediated improvement in the specificity of 1-beta-D-arabinofuranosylcytosine and 5-fluorouracil in L 1210 leukemia-bearing mice.
    Warrington RC; Muzyka TG; Fang WD
    Cancer Res; 1984 Jul; 44(7):2929-35. PubMed ID: 6722819
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Special combination of anticancer drug with its antidote for chemotherapy of hepatic metastasis in rat (author's transl)].
    Nishikawa K
    Fukuoka Igaku Zasshi; 1981 May; 72(5):290-9. PubMed ID: 7308960
    [No Abstract]   [Full Text] [Related]  

  • 55. [Antitumor spectrum of 7-N-(p-hydroxyphenyl) mitomycin C (KW 2083) in rat ascites hepatoma].
    Sato H; Taguchi H; Kobayashi Y
    Gan No Rinsho; 1982; 28(2):122-4. PubMed ID: 6820669
    [No Abstract]   [Full Text] [Related]  

  • 56. Membrane affinity and metabolism of N4-palmitoyl-1-beta-D-arabinofuranosylcytosine into cultured KB cells.
    Tsuruo T; Iida H; Hori K; Tsukagoshi S; Sakurai Y
    Cancer Res; 1981 Nov; 41(11 Pt 1):4484-8. PubMed ID: 7306971
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Enhanced therapeutic effect of cis-diamminedichloroplatinum(II) against nude mouse grown human pancreatic adenocarcinoma when combined with 1-beta-D-arabinofuranosylcytosine and caffeine.
    Kyriazis AP; Kyriazis AA; Yagoda A
    Cancer Res; 1985 Dec; 45(12 Pt 1):6083-7. PubMed ID: 4063965
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intracavitary administration: pharmacokinetic advantages of macromolecular anticancer agents against peritoneal and pleural carcinomatoses.
    Kimura M; Konno T; Miyamoto Y; Kojima Y; Maeda H
    Anticancer Res; 1998; 18(4A):2547-50. PubMed ID: 9703908
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of the interval between high dose 1-beta-D-arabinofuranosylcytosine injections on leukemic cell load, intestinal toxicity, and normal hematopoietic stem cells in a rat model for acute myelogenous leukemia.
    Colly LP; Peters WG; Willemze R
    Cancer Res; 1986 Aug; 46(8):3825-7. PubMed ID: 3460691
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oral activity of 1-beta-D-arabinofuranosylcytosine in a transplantable hamster melanoma.
    Goldenberg DM
    Chemotherapy; 1971; 16(5):294-9. PubMed ID: 5146952
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.